MRC1 and pituitary adenocarcinoma: No reports have yet examined the correlation between PD-L1 and MMR gene expressions in other benign tumors, so further studies are needed, especially regarding the association of their expressions in PAs as benign tumors and in pituitary carcinomas as malignant tumors.